Search for tag: "cantos"

ESC 2017: Highlights of late breaking trials

Dr. Steve Nissen discusses the results of three important late breaking trials looking at the impact of three drugs on cardiovascular endpoints: the CANTOS trial (Canakinumab); the REVEAL study…

From  ConsultQD Live Admin 0 likes 23 plays